Waldencast Acquisition Corp

Waldencast Plc develops and operates a beauty and wellness platform by developing, acquiring, accelerating, and scaling the next generation of conscious, purpose-driven brands. It intends to seek brands with a direct connection to consumers whose goals include pursuing social responsibility, inclusiveness, sustainability, and transparency. The company was founded by Michel Brousset and Hind Sebti in December 2020 and is headquartered in White Plains, NY.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Waldencast Plc develops and operates a beauty and wellness platform by developing, acquiring, accelerating, and scaling the next generation of conscious, purpose-driven brands. It intends to seek brands with a direct connection to consumers whose goals include pursuing social responsibility, inclusiveness, sustainability, and transparency. The company was founded by Michel Brousset and Hind Sebti on December 8, 2020 and is headquartered in White Plains, NY.

NEW YORK, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, announced today that Hind Sebti, Kelly Brookie and Roberto Thompson have been appointed to its board of Directors (the “Board”), effective September 26, 2024. These executives bring extensive professional experience further enhancing the breadth of talent and expertise possessed by the Board. Ms. Brookie will replace Sarah Brown who has informed the Board of her intention to not renew her mandate ahead of the Company's Annual General Meeting. The Company also announced that its Annual General Meeting is scheduled for October 28, 2024 during which the Company's shareholders will be asked to vote on the renewal of Class I and Class II directors. Following this announcement, the Board will include 11 members, each of whom possesses significant expertise, particularly in the beauty, financial and consumer products sectors.

Waldencast plc Announces Board Appointments and Annual General Meeting

These New Products are the Latest Innovation to Obagi's ELASTIDERM® Collection These New Products are the Latest Innovation to Obagi's ELASTIDERM® Collection

Obagi Medical Announces the Launch of ELASTIDERM® Lift Up & Sculpt Facial Moisturizer and ELASTIDERM® Advanced Filler Concentrate

Waldencast plc. (NASDAQ:WALD ) Q2 2024 Earnings Conference Call August 28, 2024 8:30 AM ET Company Participants Allison Malkin - Investor Relations, ICR Michel Brousset - Founder & Chief Executive Officer Manuel Manfredi - Chief Financial Officer Conference Call Participants Olivia Tong - Raymond James Linda Bolton Weiser - DA Davidson Dana Telsey - Telsey Advisory Group Operator Greetings.

Waldencast plc (WALD) Q2 2024 Earnings Call Transcript

Waldencast posted Q2 sales that came in far above the market's expectations. Comparable sales growth accelerated significantly on a sequential quarterly basis.

Why Waldencast Stock Is Skyrocketing Today

$63.3 million of Net Revenue Q2 2024 +25.7% net revenue Comparable Growth: +30.9% Obagi Medical and +20.0% Milk Makeup vs Q2 2023 Adjusted EBITDA of $6.3 million, up +64.5% vs Q2 2023

Waldencast Reports Q2 2024 Financial Results

NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, provided second quarter and first half fiscal 2024 earnings conference call and webcast information. As previously announced, the Company will report second quarter and first half fiscal 2024 earnings on August 27th, after the close of the U.S. stock market. The Company will conduct a conference call to discuss its earnings results on Wednesday, August 28, 2024 at 8:30am ET.

Waldencast plc Provides Second Quarter and First Half Fiscal 2024 Earnings Conference Call and Webcast Information

Coty

Inter Parfums

Olaplex Holdings

The Zacks Cosmetics industry is grappling with elevated inflationary pressures. Coty, Inter Parfums (IPAR), Waldencast (WALD) and Olaplex (OLPX) are capitalizing on digital advancements and innovative strategies.

4 Cosmetics Stocks Worth Watching Amid Industry Challenges

WHITE PLAINS, N.Y., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today announced that the Company will participate in the Canaccord Genuity 44th Annual Growth Conference being held at the InterContinental Boston Hotel in Boston, Massachusetts.

Waldencast Announces Participation in the Canaccord Genuity 44th Annual Growth Conference

WHITE PLAINS, N.Y., June 27, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, announced upcoming earnings release, conference call and webcast dates.

Waldencast plc Announces Upcoming Earnings Release and Conference Call Dates

WHITE PLAINS, N.Y., May 30, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today announced that the Company will participate in upcoming investor conferences.

Waldencast Announces Participation in Upcoming Investor Conferences

Waldencast plc (NASDAQ:WALD ) Q1 2024 Earnings Conference Call May 22, 2024 8:30 AM ET Company Participants Allison Malkin - Investor Relations, ICR Michel Brousset - Founder & Chief Executive Officer Manuel Manfredi - Chief Financial Officer Conference Call Participants Jonna Kim - TD Cowen Dana Telsey - Telsey Advisory Group Linda Bolton Weiser - D.A. Davidson Operator Greetings.

Waldencast plc (WALD) Q1 2024 Earnings Call Transcript

$68.3 million of Net Revenue+21.0% Comparable Net Revenue: +20.6% Obagi Skincare and +21.5% Milk MakeupAdjusted EBITDA of $11.4 million, up +12.9% vs Q1 2023

Waldencast Reports Q1 2024 Financial Results

NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, announced that it will release its first quarter fiscal 2024 earnings results before the U.S. stock market opens on Tuesday, May 21, 2024. The Company will conduct a conference call to discuss its earnings results on the same day at 8:30am ET.

Waldencast plc Announces First Quarter Fiscal 2024 Earnings Release Date, Conference Call and Webcast

NEW YORK, May 01, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast” or “the Company”), a global multi-brand beauty and wellness platform, today announced its participation in the CreatorIQ Connect Europe conference, which will be held in London on Thursday, May 2, 2024.

Waldencast Announces Participation in CreatorIQ Connect Europe

2023 Net Revenue of $218.1 millionGroup Combined Comparable Revenue of $212.5 million, a 15.3% increase vs 2022Group Combined Adjusted EBITDA of $24.4 million, up from ($8.8) million in 2022

Waldencast Reports Fiscal Year 2023 Financial Results

NEW YORK , April 21, 2024 /PRNewswire/ --  WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Waldencast plc (NASDAQ: WALD, WALDW) resulting from allegations that Waldencast may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Waldencast securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Waldencast plc Investors to Inquire About Securities Class Action Investigation - WALD, WALDW

NEW YORK , April 15, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Waldencast plc (NASDAQ: WALD, WALDW) resulting from allegations that Waldencast may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Waldencast securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

TOP RANKED ROSEN LAW FIRM Encourages Waldencast plc Investors to Inquire About Securities Class Action Investigation - WALD, WALDW

NEW YORK , April 5, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Waldencast plc (NASDAQ: WALD, WALDW) resulting from allegations that Waldencast may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Waldencast securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN,A TOP RANKED LAW FIRM, Encourages Waldencast plc Investors to Inquire About Securities Class Action Investigation - WALD, WALDW

WHITE PLAINS, N.Y., March 25, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, announced that on March 21, 2024 the Company received formal notice from the Nasdaq Hearings Panel (the “Panel”) confirming that it has regained compliance with Nasdaq's filing requirements, as set forth in Nasdaq Listing Rule 5250(c) (the “Periodic Filing Rule”) following the filing of the Company's financial results for the interim period ended June 30, 2023 with the U.S. Securities and Exchange Commission. In line with the applicable Nasdaq Listing Rules in such circumstances, the notice also indicated that Nasdaq had imposed a “Mandatory Panel Monitor” as that term is defined in Nasdaq Listing Rule 5815(d)(4)(B), for a period of one year from the date of the compliance determination (March 21, 2024), pursuant to which in the event the Company fails to timely satisfy the Periodic Filing Rule during the one-year monitor period, the Company will not have the opportunity to provide a compliance plan for the Nasdaq Listing Qualifications Staff's review; rather, Nasdaq would instead issue a delist determination pursuant to which the Company could request a hearing and stay of the delist determination pending another hearing before the Panel.

Waldencast Regains Compliance with Nasdaq Filing Requirements

NEW YORK, March 24, 2024 /PRNewswire/ -- WHY:  Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Waldencast plc (NASDAQ: WALD, WALDW) resulting from allegations that Waldencast may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Waldencast securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Waldencast plc Investors to Inquire About Securities Class Action Investigation - WALD, WALDW

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Johnson Fistel, LLP is investigating whether Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws. What if I purchased Waldencast securities? If you purchased secur.

Johnson Fistel, LLP is Investigating Waldencast for Violation of Securities Laws; WALD, WALDW

—  H1'23 Total Net Revenue of $109.3 million—  H1'23 Combined Adjusted EBITDA of $13.9 million up from $7.6 million in H1'22—  Introduces guidance

Waldencast Reports First Half 2023 Results

NEW YORK , March 17, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Waldencast PLC (NASDAQ: WALD, WALDW) resulting from allegations that Waldencast may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Waldencast securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

ROSEN, LEADING INVESTOR COUNSEL, Encourages Waldencast plc Investors to Inquire About Securities Class Action Investigation - WALD, WALDW

NEW YORK , March 11, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Waldencast plc ("Waldencast" or the "Company") (NASDAQ: WALD).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsOn Behalf of Investors of Waldencast plc - WALD

NEW YORK , March 8, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Waldencast PLC (NASDAQ: WALD, WALDW) resulting from allegations that Waldencast may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Waldencast securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

News for Waldencast Acquisition Corp Stock (WALD)